vs
Axil Brands, Inc.（AXIL）与IRIDEX CORP（IRIX）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是Axil Brands, Inc.的1.8倍（$14.7M vs $8.1M），Axil Brands, Inc.同比增速更快（5.2% vs -69.7%），过去两年Axil Brands, Inc.的营收复合增速更高（12.1% vs 11.9%）
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
AXIL vs IRIX — 直观对比
营收规模更大
IRIX
是对方的1.8倍
$8.1M
营收增速更快
AXIL
高出74.9%
-69.7%
两年增速更快
AXIL
近两年复合增速
11.9%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $8.1M | $14.7M |
| 净利润 | $704.9K | — |
| 毛利率 | 68.1% | 37.2% |
| 营业利润率 | 11.1% | — |
| 净利率 | 8.7% | — |
| 营收同比 | 5.2% | -69.7% |
| 净利润同比 | 11.2% | — |
| 每股收益（稀释后） | $0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXILIRIX
| Q4 25 | $8.1M | $14.7M | ||
| Q3 25 | $6.9M | $12.5M | ||
| Q2 25 | $5.8M | $13.6M | ||
| Q1 25 | $6.9M | $11.9M | ||
| Q4 24 | $7.7M | $12.7M | ||
| Q3 24 | $5.9M | $11.6M | ||
| Q2 24 | $6.5M | $12.6M | ||
| Q1 24 | $6.5M | $11.8M |
净利润AXILIRIX
| Q4 25 | $704.9K | — | ||
| Q3 25 | $334.3K | $-1.6M | ||
| Q2 25 | $-245.6K | $-994.0K | ||
| Q1 25 | $576.7K | $-1.7M | ||
| Q4 24 | $633.7K | $-834.0K | ||
| Q3 24 | $-109.8K | $-1.9M | ||
| Q2 24 | $49.5K | $-2.7M | ||
| Q1 24 | $781.1K | $-3.5M |
毛利率AXILIRIX
| Q4 25 | 68.1% | 37.2% | ||
| Q3 25 | 67.6% | 32.1% | ||
| Q2 25 | 70.0% | 34.5% | ||
| Q1 25 | 71.7% | 42.5% | ||
| Q4 24 | 71.1% | 44.0% | ||
| Q3 24 | 71.0% | 37.3% | ||
| Q2 24 | 71.5% | 40.7% | ||
| Q1 24 | 71.5% | 37.9% |
营业利润率AXILIRIX
| Q4 25 | 11.1% | — | ||
| Q3 25 | 6.0% | -11.3% | ||
| Q2 25 | 0.8% | -6.9% | ||
| Q1 25 | 8.4% | -1.7% | ||
| Q4 24 | 8.7% | -3.9% | ||
| Q3 24 | -2.4% | -16.1% | ||
| Q2 24 | 2.6% | -20.9% | ||
| Q1 24 | -1.6% | -28.0% |
净利率AXILIRIX
| Q4 25 | 8.7% | — | ||
| Q3 25 | 4.9% | -12.6% | ||
| Q2 25 | -4.3% | -7.3% | ||
| Q1 25 | 8.3% | -14.2% | ||
| Q4 24 | 8.2% | -6.6% | ||
| Q3 24 | -1.9% | -16.7% | ||
| Q2 24 | 0.8% | -21.2% | ||
| Q1 24 | 12.1% | -29.5% |
每股收益（稀释后）AXILIRIX
| Q4 25 | $0.09 | — | ||
| Q3 25 | $0.04 | $-0.09 | ||
| Q2 25 | $-0.03 | $-0.06 | ||
| Q1 25 | $0.07 | $-0.10 | ||
| Q4 24 | $0.08 | $-0.05 | ||
| Q3 24 | $-0.02 | $-0.12 | ||
| Q2 24 | $0.11 | $-0.16 | ||
| Q1 24 | $0.04 | $-0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $5.0M | $6.0M |
| 总债务越低越好 | $138.3K | — |
| 股东权益账面价值 | $11.1M | — |
| 总资产 | $16.2M | $29.2M |
| 负债/权益比越低杠杆越低 | 0.01× | — |
8季度趋势，按日历期对齐
现金及短期投资AXILIRIX
| Q4 25 | $5.0M | $6.0M | ||
| Q3 25 | $4.1M | $5.6M | ||
| Q2 25 | $4.8M | $6.8M | ||
| Q1 25 | $4.7M | $7.2M | ||
| Q4 24 | $5.2M | $2.4M | ||
| Q3 24 | $4.1M | $3.9M | ||
| Q2 24 | $3.3M | $4.1M | ||
| Q1 24 | $4.9M | $5.4M |
总债务AXILIRIX
| Q4 25 | $138.3K | — | ||
| Q3 25 | $139.2K | — | ||
| Q2 25 | $140.2K | — | ||
| Q1 25 | $141.0K | — | ||
| Q4 24 | $143.3K | $1.0M | ||
| Q3 24 | $144.3K | $1.4M | ||
| Q2 24 | $146.6K | — | ||
| Q1 24 | — | — |
股东权益AXILIRIX
| Q4 25 | $11.1M | — | ||
| Q3 25 | $10.2M | $4.7M | ||
| Q2 25 | $9.7M | $6.1M | ||
| Q1 25 | $9.7M | $852.0K | ||
| Q4 24 | $8.8M | $2.1M | ||
| Q3 24 | $7.9M | $2.6M | ||
| Q2 24 | $7.7M | $4.2M | ||
| Q1 24 | $8.8M | $6.5M |
总资产AXILIRIX
| Q4 25 | $16.2M | $29.2M | ||
| Q3 25 | $15.4M | $28.4M | ||
| Q2 25 | $12.9M | $31.6M | ||
| Q1 25 | $13.0M | $34.2M | ||
| Q4 24 | $13.7M | $29.1M | ||
| Q3 24 | $11.4M | $30.2M | ||
| Q2 24 | $11.0M | $31.2M | ||
| Q1 24 | $12.7M | $34.1M |
负债/权益比AXILIRIX
| Q4 25 | 0.01× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.01× | — | ||
| Q1 25 | 0.01× | — | ||
| Q4 24 | 0.02× | 0.48× | ||
| Q3 24 | 0.02× | 0.53× | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $934.8K | — |
| 自由现金流经营现金流 - 资本支出 | $906.4K | — |
| 自由现金流率自由现金流/营收 | 11.1% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 1.33× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AXILIRIX
| Q4 25 | $934.8K | — | ||
| Q3 25 | $-739.2K | $-1.2M | ||
| Q2 25 | $194.4K | $-397.0K | ||
| Q1 25 | $-169.9K | $-1.1M | ||
| Q4 24 | $1.0M | $-1.2M | ||
| Q3 24 | $897.3K | $-3.1M | ||
| Q2 24 | $-336.6K | $-1.3M | ||
| Q1 24 | $-912.8K | $-1.6M |
自由现金流AXILIRIX
| Q4 25 | $906.4K | — | ||
| Q3 25 | $-747.6K | $-1.2M | ||
| Q2 25 | — | $-410.0K | ||
| Q1 25 | $-258.2K | $-1.2M | ||
| Q4 24 | $941.1K | $-1.2M | ||
| Q3 24 | — | $-3.1M | ||
| Q2 24 | $-394.9K | — | ||
| Q1 24 | $-922.1K | $-1.7M |
自由现金流率AXILIRIX
| Q4 25 | 11.1% | — | ||
| Q3 25 | -10.9% | -9.4% | ||
| Q2 25 | — | -3.0% | ||
| Q1 25 | -3.7% | -9.8% | ||
| Q4 24 | 12.2% | -9.8% | ||
| Q3 24 | — | -26.5% | ||
| Q2 24 | -6.1% | — | ||
| Q1 24 | -14.3% | -14.0% |
资本支出强度AXILIRIX
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.1% | 0.1% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 0.9% | 0.1% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 0.9% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率AXILIRIX
| Q4 25 | 1.33× | — | ||
| Q3 25 | -2.21× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.29× | — | ||
| Q4 24 | 1.59× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6.80× | — | ||
| Q1 24 | -1.17× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
IRIX
暂无分部数据
